{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:04:33Z","timestamp":1785186273035,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11060-020-03557-x","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T14:03:00Z","timestamp":1596636180000},"page":"85-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas"],"prefix":"10.1007","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-7818","authenticated-orcid":false,"given":"David H.","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn F.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley P.","family":"Ghiaseddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"3557_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-7091-9160-6_23","volume":"52","author":"M Bettag","year":"1991","unstructured":"Bettag M et al (1991) Stereotactic laser therapy in cerebral gliomas. Acta Neurochir Suppl (Wien) 52:81\u201383","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"3557_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000100263","volume":"54\u201355","author":"K Sugiyama","year":"1990","unstructured":"Sugiyama K et al (1990) Stereotactic interstitial laser-hyperthermia using Nd-YAG laser. Stereotact Funct Neurosurg 54\u201355:501\u2013505","journal-title":"Stereotact Funct Neurosurg"},{"issue":"Suppl 1","key":"3557_CR3","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1227\/NEU.0000000000001443","volume":"79","author":"I Lee","year":"2016","unstructured":"Lee I, Kalkanis S, Hadjipanayis CG (2016) Stereotactic laser interstitial thermal therapy for recurrent high-grade gliomas. Neurosurgery 79(Suppl 1):S24\u2013S34","journal-title":"Neurosurgery"},{"issue":"4","key":"3557_CR4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nec.2017.05.015","volume":"28","author":"D Silva","year":"2017","unstructured":"Silva D et al (2017) Magnetic resonance thermometry and laser interstitial thermal therapy for brain tumors. Neurosurg Clin N Am 28(4):525\u2013533","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"3557_CR5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/neuros\/nyx518","volume":"83","author":"TL Beaumont","year":"2018","unstructured":"Beaumont TL et al (2018) Magnetic resonance imaging-guided laser interstitial thermal therapy for glioblastoma of the corpus callosum. Neurosurgery 83(3):556\u2013565","journal-title":"Neurosurgery"},{"issue":"4","key":"3557_CR6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cam4.266","volume":"3","author":"AM Mohammadi","year":"2014","unstructured":"Mohammadi AM et al (2014) The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med 3(4):971\u2013979","journal-title":"Cancer Med"},{"issue":"6","key":"3557_CR7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2014.9.FOCUS14471","volume":"37","author":"AH Hawasli","year":"2014","unstructured":"Hawasli AH et al (2014) Stereotactic laser ablation of high-grade gliomas. Neurosurg Focus 37(6):E1","journal-title":"Neurosurg Focus"},{"issue":"8","key":"3557_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11912-019-0818-y","volume":"21","author":"FS Ali","year":"2019","unstructured":"Ali FS et al (2019) Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities. Curr Oncol Rep 21(8):66","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"3557_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000338251","volume":"90","author":"G Rahmathulla","year":"2012","unstructured":"Rahmathulla G et al (2012) Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90(3):192\u2013200","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2","key":"3557_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/14737175.2016.1135736","volume":"16","author":"M Sharma","year":"2016","unstructured":"Sharma M et al (2016) Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview. Expert Rev Neurother 16(2):223\u2013232","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"3557_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.nec.2017.06.001","volume":"28","author":"RY North","year":"2017","unstructured":"North RY, Raskin JS, Curry DJ (2017) MRI-guided laser interstitial thermal therapy for epilepsy. Neurosurg Clin N Am 28(4):545\u2013557","journal-title":"Neurosurg Clin N Am"},{"issue":"9","key":"3557_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11910-017-0772-8","volume":"17","author":"E Prince","year":"2017","unstructured":"Prince E et al (2017) Laser interstitial thermal therapy for epilepsy. Curr Neurol Neurosci Rep 17(9):63","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3557_CR13","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2147\/NDT.S139544","volume":"13","author":"ND Shukla","year":"2017","unstructured":"Shukla ND et al (2017) Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date. Neuropsychiatr Dis Treat 13:2469\u20132475","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"Suppl 1","key":"3557_CR14","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1227\/NEU.0000000000001439","volume":"79","author":"RT Wicks","year":"2016","unstructured":"Wicks RT et al (2016) Laser interstitial thermal therapy for mesial temporal lobe epilepsy. Neurosurgery 79(Suppl 1):S83\u2013S91","journal-title":"Neurosurgery"},{"issue":"4","key":"3557_CR15","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2016.7.FOCUS16224","volume":"41","author":"S Pisipati","year":"2016","unstructured":"Pisipati S et al (2016) Intracerebral laser interstitial thermal therapy followed by tumor resection to minimize cerebral edema. Neurosurg Focus 41(4):E13","journal-title":"Neurosurg Focus"},{"issue":"4","key":"3557_CR16","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2016.8.FOCUS16233","volume":"41","author":"J Wright","year":"2016","unstructured":"Wright J et al (2016) Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. Neurosurg Focus 41(4):E14","journal-title":"Neurosurg Focus"},{"issue":"1","key":"3557_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40644-019-0250-4","volume":"19","author":"U Salem","year":"2019","unstructured":"Salem U et al (2019) Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT). Cancer Imaging 19(1):65","journal-title":"Cancer Imaging"},{"issue":"2","key":"3557_CR18","doi-asserted-by":"crossref","first-page":"e0148613","DOI":"10.1371\/journal.pone.0148613","volume":"11","author":"EC Leuthardt","year":"2016","unstructured":"Leuthardt EC et al (2016) Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier. PLoS ONE 11(2):e0148613","journal-title":"PLoS ONE"},{"key":"3557_CR19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/1567201816666190828153017","volume":"16","author":"NI Mansor","year":"2019","unstructured":"Mansor NI et al (2019) Crossing the blood-brain barrier: a review on drug delivery strategies for treatment of the central nervous system diseases. Curr Drug Deliv 16:698\u2013711","journal-title":"Curr Drug Deliv"},{"issue":"9","key":"3557_CR20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","volume":"22","author":"DS Hersh","year":"2016","unstructured":"Hersh DS et al (2016) Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharm Des 22(9):1177\u20131193","journal-title":"Curr Pharm Des"},{"issue":"4","key":"3557_CR21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","volume":"1788","author":"N Weiss","year":"2009","unstructured":"Weiss N et al (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788(4):842\u2013857","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"3557_CR22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/18715206113139990029","volume":"14","author":"Z Wang","year":"2014","unstructured":"Wang Z, Sun H, Yakisich JS (2014) Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems. Anticancer Agents Med Chem 14(8):1085\u20131093","journal-title":"Anticancer Agents Med Chem"},{"issue":"12","key":"3557_CR23","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2174\/138920112803341798","volume":"13","author":"C Zhan","year":"2012","unstructured":"Zhan C, Lu W (2012) The blood-brain\/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery. Curr Pharm Biotechnol 13(12):2380\u20132387","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"3557_CR24","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann S et al (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10(11):3728\u20133736","journal-title":"Clin Cancer Res"},{"key":"3557_CR25","doi-asserted-by":"crossref","first-page":"e52176","DOI":"10.7554\/eLife.52176","volume":"9","author":"AR Pombo Antunes","year":"2020","unstructured":"Pombo Antunes AR et al (2020) Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies. eLife. 9:e52176","journal-title":"eLife."},{"issue":"8","key":"3557_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","volume":"16","author":"K Aldape","year":"2019","unstructured":"Aldape K et al (2019) Challenges to curing primary brain tumours. Nat Rev Clin Oncol 16(8):509\u2013520","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"3557_CR27","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","volume":"25","author":"W Tomaszewski","year":"2019","unstructured":"Tomaszewski W et al (2019) Brain tumor microenvironment and host state: implications for immunotherapy. Clin Cancer Res 25(14):4202\u20134210","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3557_CR28","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awl173","volume":"129","author":"G Tabatabai","year":"2006","unstructured":"Tabatabai G et al (2006) Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-\u03b2-dependent HIF-1\u03b1-mediated induction of CXCL12. Brain 129(9):2426\u20132435","journal-title":"Brain"},{"issue":"12","key":"3557_CR29","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/bjc.2011.169","volume":"104","author":"D Tseng","year":"2011","unstructured":"Tseng D, Vasquez-Medrano DA, Brown JM (2011) Targeting SDF-1\/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. Br J Cancer 104(12):1805\u20131809","journal-title":"Br J Cancer"},{"key":"3557_CR30","first-page":"476","volume":"130","author":"MA Vogelbaum","year":"2018","unstructured":"Vogelbaum MA et al (2018) First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1. J Neurosurg 130:476\u2013485","journal-title":"J Neurosurg"},{"issue":"26","key":"3557_CR31","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown CE et al (2016) Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N Engl J Med 375(26):2561\u20132569","journal-title":"N Engl J Med"},{"key":"3557_CR32","doi-asserted-by":"crossref","unstructured":"Eichberg DG et al. (2019) multiple iterations of magnetic resonance-guided laser interstitial thermal ablation of brain metastases: single surgeon's experience and review of the literature. Oper Neurosurg (Hagerstown)","DOI":"10.1093\/ons\/opz375"},{"issue":"2","key":"3557_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2214\/ajr.174.2.1740323","volume":"174","author":"SN Goldberg","year":"2000","unstructured":"Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174(2):323\u2013331","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"3557_CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14764172.2017.1349321","volume":"19","author":"FN Mirza","year":"2017","unstructured":"Mirza FN, Khatri KA (2017) The use of lasers in the treatment of skin cancer: a review. J Cosmet Laser Ther 19(8):451\u2013458","journal-title":"J Cosmet Laser Ther"},{"issue":"12","key":"3557_CR35","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1111\/j.1572-0241.2002.07117.x","volume":"97","author":"AP Weston","year":"2002","unstructured":"Weston AP, Sharma P (2002) Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97(12):2998\u20133006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3557_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1249\/JSR.0000000000000438","volume":"17","author":"MJ Ellis","year":"2018","unstructured":"Ellis MJ et al (2018) Management of an adolescent athlete with sports-related concussion and intraparenchymal hemorrhage. Curr Sports Med Rep 17(1):7\u20139","journal-title":"Curr Sports Med Rep"},{"issue":"1","key":"3557_CR37","doi-asserted-by":"crossref","first-page":"e27878","DOI":"10.4161\/onci.27878","volume":"3","author":"E Vacchelli","year":"2014","unstructured":"Vacchelli E et al (2014) Trial watch: chemotherapy with immunogenic cell death inducers. Oncoimmunology 3(1):e27878","journal-title":"Oncoimmunology"},{"issue":"10","key":"3557_CR38","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1021\/acsnano.9b06040","volume":"13","author":"Y Ma","year":"2019","unstructured":"Ma Y et al (2019) Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy. ACS Nano 13(10):11967\u201311980","journal-title":"ACS Nano"},{"issue":"3","key":"3557_CR39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuroscience.2009.04.004","volume":"161","author":"EA Kiyatkin","year":"2009","unstructured":"Kiyatkin EA, Sharma HS (2009) Permeability of the blood-brain barrier depends on brain temperature. Neuroscience 161(3):926\u2013939","journal-title":"Neuroscience"},{"key":"3557_CR40","first-page":"307","volume":"8","author":"H Wang","year":"2014","unstructured":"Wang H et al (2014) Brain temperature and its fundamental properties: a review for clinical neuroscientists. Front Neurosci 8:307","journal-title":"Front Neurosci"},{"issue":"9","key":"3557_CR41","doi-asserted-by":"crossref","first-page":"e0222113","DOI":"10.1371\/journal.pone.0222113","volume":"14","author":"T Yamaguchi","year":"2019","unstructured":"Yamaguchi T et al (2019) Effect of heat stress on blood-brain barrier integrity in iPS cell-derived microvascular endothelial cell models. PLoS ONE 14(9):e0222113","journal-title":"PLoS ONE"},{"key":"3557_CR42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2015.11.043","volume":"1631","author":"C Ji","year":"2016","unstructured":"Ji C et al (2016) Hyperthermia exacerbates the effects of cathepsin L on claudin-1 in a blood-brain barrier model in vitro. Brain Res 1631:72\u201379","journal-title":"Brain Res"},{"issue":"1","key":"3557_CR43","first-page":"21","volume":"23","author":"YZ Chen","year":"2003","unstructured":"Chen YZ et al (2003) Effect of hyperthermia on tight junctions between endothelial cells of the blood-brain barrier model in vitro. Di Yi Jun Yi Da Xue Xue Bao 23(1):21\u201324","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"issue":"2","key":"3557_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/lsm.10181","volume":"33","author":"M Sabel","year":"2003","unstructured":"Sabel M et al (2003) Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Lasers Surg Med 33(2):75\u201380","journal-title":"Lasers Surg Med"},{"issue":"12","key":"3557_CR45","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/neuonc\/now137","volume":"18","author":"G Appelboom","year":"2016","unstructured":"Appelboom G et al (2016) Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery. Neuro Oncol 18(12):1601\u20131609","journal-title":"Neuro Oncol"},{"issue":"6","key":"3557_CR46","doi-asserted-by":"crossref","first-page":"e0179131","DOI":"10.1371\/journal.pone.0179131","volume":"12","author":"C Rossmann","year":"2017","unstructured":"Rossmann C et al (2017) Temperature sensitive liposomes combined with thermal ablation: effects of duration and timing of heating in mathematical models and in vivo. PLoS ONE 12(6):e0179131","journal-title":"PLoS ONE"},{"key":"3557_CR47","doi-asserted-by":"crossref","first-page":"9251375","DOI":"10.1155\/2016\/9251375","volume":"2016","author":"A Mehta","year":"2016","unstructured":"Mehta A, Oklu R, Sheth RA (2016) Thermal ablative therapies and immune checkpoint modulation: can locoregional approaches effect a systemic response? Gastroenterol Res Pract 2016:9251375","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"3557_CR48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/02656739609023698","volume":"12","author":"K Kakinuma","year":"1996","unstructured":"Kakinuma K et al (1996) Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int J Hyperthermia 12(1):157\u2013165","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"3557_CR49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3171\/jns.1996.84.2.0180","volume":"84","author":"K Kakinuma","year":"1996","unstructured":"Kakinuma K et al (1996) Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia. J Neurosurg 84(2):180\u2013184","journal-title":"J Neurosurg"},{"issue":"1","key":"3557_CR50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/10717544.2018.1461280","volume":"25","author":"AL Bredlau","year":"2018","unstructured":"Bredlau AL et al (2018) Localized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive liposomes. Drug Deliv 25(1):973\u2013984","journal-title":"Drug Deliv"},{"key":"3557_CR51","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski S et al (2018) Photodynamic therapy-mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098\u20131107","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3557_CR52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2012.09.012","volume":"334","author":"CK Lim","year":"2013","unstructured":"Lim CK et al (2013) Nanophotosensitizers toward advanced photodynamic therapy of Cancer. Cancer Lett 334(2):176\u2013187","journal-title":"Cancer Lett"},{"issue":"4","key":"3557_CR53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis P et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250\u2013281","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3557_CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","volume":"3","author":"DE Dolmans","year":"2003","unstructured":"Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380\u2013387","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3557_CR55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pdpdt.2010.02.002","volume":"7","author":"S Eljamel","year":"2010","unstructured":"Eljamel S (2010) Photodynamic applications in brain tumors: a comprehensive review of the literature. Photodiagnosis Photodyn Ther 7(2):76\u201385","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3557_CR56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fsurg.2019.00081","volume":"6","author":"SW Cramer","year":"2019","unstructured":"Cramer SW, Chen CC (2019) Photodynamic therapy for the treatment of glioblastoma. Front Surg 6:81","journal-title":"Front Surg"},{"issue":"2","key":"3557_CR57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2015.01.029","volume":"359","author":"F Zhou","year":"2015","unstructured":"Zhou F et al (2015) InCVAX\u2013a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Lett 359(2):169\u2013177","journal-title":"Cancer Lett"},{"key":"3557_CR58","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000438","author":"X Qi","year":"2016","unstructured":"Qi X et al (2016) Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer. J Clin Cell Immunol. https:\/\/doi.org\/10.4172\/2155-9899.1000438","journal-title":"J Clin Cell Immunol"},{"issue":"5","key":"3557_CR59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jbio.201600271","volume":"10","author":"MF Naylor","year":"2017","unstructured":"Naylor MF et al (2017) Treatment of advanced melanoma with laser immunotherapy and ipilimumab. J Biophoton 10(5):618\u2013622","journal-title":"J Biophoton"},{"issue":"4","key":"3557_CR60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s11481-013-9470-8","volume":"8","author":"JD Laman","year":"2013","unstructured":"Laman JD, Weller RO (2013) Drainage of cells and soluble antigen from the CNS to regional lymph nodes. J Neuroimmune Pharmacol 8(4):840\u2013856","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"3557_CR61","first-page":"6280","volume":"21","author":"D Tran","year":"2019","unstructured":"Tran D et al (2019) SCIDOT-43. Final data analysis of a pilot study testing the efficacy of using laser interstitial thermal therapy (LITT) to induce temporary disruption of the peritumoral blood brain barrier (BBB) to improve effectiveness of BBB-impermeant chemotherapy in recurrent glioblastoma. Neuro Oncol 21(6):6280\u20136281","journal-title":"Neuro Oncol"},{"issue":"6","key":"3557_CR62","first-page":"611","volume":"21","author":"J Campian","year":"2019","unstructured":"Campian J et al (2019) ATIM-45. long term follow-up of a phase I\/II study testing the toxicities and efficacy of pembrolizumab in combination with MRI-guided laser interstitial thermal therapy (LITT) in recurrent malignant gliomas. Neuro Oncol 21(6):611","journal-title":"Neuro Oncol"},{"key":"3557_CR63","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/j.wneu.2018.06.092","volume":"117","author":"SC Ali","year":"2018","unstructured":"Ali SC et al (2018) The safety of bevacizumab administered shortly after laser interstitial thermal therapy in glioblastoma: a case series. World Neurosurg 117:e588\u2013e594","journal-title":"World Neurosurg"},{"key":"3557_CR64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2016.01.004","volume":"39","author":"EM Verdegaal","year":"2016","unstructured":"Verdegaal EM (2016) Adoptive cell therapy: a highly successful individualized therapy for melanoma with great potential for other malignancies. Curr Opin Immunol 39:90\u201395","journal-title":"Curr Opin Immunol"},{"key":"3557_CR65","doi-asserted-by":"crossref","unstructured":"De Santis CE et al. (2019) Breast cancer statistics 2019. CA Cancer J Clin.","DOI":"10.3322\/caac.21583"},{"issue":"4","key":"3557_CR66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE et al (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252\u2013271","journal-title":"CA Cancer J Clin"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03557-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:09:39Z","timestamp":1628118579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03557-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3557"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03557-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"David H. Shin declares that he has no conflict of interest. Kaitlyn F. Melnick declares that she has no conflict of interest. David D. Tran is one of the primary investigators in the referenced trial at this institution (NCT02311582). David D. Tran also has received grant funding from Celldex, NWBiotech, Novocure, and Merck. David D. Tran has received personal fees from Novocure and prIME Oncology. Ashley P. Ghiaseddin has received personal fees from Monteris Medical. Ashley P. Ghiaseddin has also received research funding support from Orbus Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}